PB2032: MAGNETISMM-9: AN OPEN-LABEL, MULTICENTER, NON-RANDOMIZED PHASE 1/2 STUDY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

ABSTRACT:

SUBMITTER: Fonseca R 

PROVIDER: S-EPMC9429252 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature